CAROLINE HENDLEY: Open Payments
NPI 1679962807 · ADEL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,565 in 76 payments from 16 companies in 2025. Trend: 2023 $1,254 · 2024 $1,004 · 2025 $1,565
Food & beverage: $1,470Education: $95
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 22 | $301 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $215 |
| AstraZeneca Pharmaceuticals LP | 8 | $169 |
| Viatris Specialty LLC | 9 | $166 |
| Regeneron Healthcare Solutions, Inc. | 6 | $141 |
| Insmed, Inc. | 5 | $134 |
| GENZYME CORPORATION | 5 | $112 |
| SANOFI-AVENTIS U.S. LLC | 1 | $95 |
| Verona Pharma, Inc. | 3 | $75 |
| Pulmonx Corporation | 2 | $34 |
Products named: DUPIXENT, TRELEGY ELLIPTA, YUPELRI, Arikayce, OFEV, AIRSUPRA, Ohtuvayre, NUCALA.
Industry payments across GA — which companies pay providers there.
